Published in N Engl J Med on July 06, 1995
Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation. J Am Soc Nephrol (2009) 3.40
Death and disability from warfarin-associated intracranial and extracranial hemorrhages. Am J Med (2007) 2.16
Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis. CMAJ (2008) 2.02
Resolution of left atrial appendage thrombus with apixaban. Thromb J (2013) 1.35
Is INR between 2.0 and 3.0 the optimal level for Chinese patients on warfarin therapy for moderate-intensity anticoagulation? Br J Clin Pharmacol (2005) 1.29
Should patient characteristics influence target anticoagulation intensity for stroke prevention in nonvalvular atrial fibrillation?: the ATRIA study. Circ Cardiovasc Qual Outcomes (2009) 1.29
Risk factors for nonadherence to warfarin: results from the IN-RANGE study. Pharmacoepidemiol Drug Saf (2008) 1.15
A new regimen for starting warfarin therapy in out-patients. Br J Clin Pharmacol (1998) 1.12
Gigantic retroperitoneal hematoma as a complication of anticoagulation therapy with heparin in therapeutic doses: a case report. J Med Case Rep (2008) 1.08
Prevention of thromboembolism in atrial fibrillation. A meta-analysis of trials of anticoagulants and antiplatelet drugs. J Gen Intern Med (2000) 1.08
Aiming for safe anticoagulation. N Engl J Med (1995) 1.07
The cost-effectiveness of different management strategies for patients on chronic warfarin therapy. J Gen Intern Med (2000) 1.02
Venous thromboembolism in the elderly. A community-based perspective. Thromb Haemost (2008) 0.99
Self-management of oral anticoagulation in nonvalvular atrial fibrillation (SMAAF study). Z Kardiol (2005) 0.93
Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression. Thromb J (2014) 0.92
Femoral Nerve Palsy due to Anticoagulant Induced Retroperitoneal Hematoma. Case Rep Med (2014) 0.91
Patient attitudinal and behavioral factors associated with warfarin non-adherence at outpatient anticoagulation clinics. Int J Behav Med (2010) 0.90
The case for an elderly targeted stroke management. Front Neurol (2011) 0.86
Anticoagulation control in the peri-hospitalization period. J Gen Intern Med (2007) 0.82
Fortnightly review: anticoagulation in heart disease. BMJ (1999) 0.81
Effectiveness and safety of warfarin and anti-platelet drugs for the primary prevention of stroke in patients with non-valvular atrial fibrillation: a meta-analysis. Int J Clin Exp Med (2015) 0.80
Emergency department ultrasound diagnosis of spontaneous iliopsoas haemorrhage in a patient on warfarin. BMJ Case Rep (2013) 0.79
Novel anticoagulants in atrial fibrillation stroke prevention. Ther Adv Chronic Dis (2012) 0.79
Optimal oral anticoagulation for patients with nonrheumatic atrial fibrillation and recent cerebral ischemia. N Engl J Med (1995) 0.78
Late thromboembolic events after circumferential pulmonary vein ablation of atrial fibrillation. J Interv Card Electrophysiol (2010) 0.78
Antithrombotic therapy for the treatment of atrial fibrillation in the elderly. J Interv Card Electrophysiol (2009) 0.77
Cardiac Causes of Stroke. Curr Treat Options Neurol (2000) 0.76
Impact of GGCX, STX1B and FPGS Polymorphisms on Warfarin Dose Requirements in European-Americans and Egyptians. Clin Transl Sci (2016) 0.76
Ezetimibe enhances and stabilizes anticoagulant effect of warfarin. Heart Vessels (2016) 0.76
The role of soluble fibrin during anticoagulant therapy: a case report. Thromb J (2015) 0.75
An audit of anticoagulant management to assess anticoagulant control using decision support software. BMJ Open (2014) 0.75
Aspirin Compared to Low Intensity Anticoagulation in Patients with Non-Valvular Atrial Fibrillation. A Systematic Review and Meta-Analysis. PLoS One (2015) 0.75
An Audit of Management of Patients on Oral Anticoagulant Therapy With International Normalized Ratio (INR) Five or Above. Indian J Hematol Blood Transfus (2012) 0.75
The Optimal Treatment For Atrial Fibrillation In Less Developed Countries. J Atr Fibrillation (2014) 0.75
Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery. Trans Am Ophthalmol Soc (2006) 0.75
Anticoagulation for non-valvular atrial aibrillation - towards a new beginning with ximelagatran. Curr Control Trials Cardiovasc Med (2004) 0.75
Spontaneous and non-spontaneous bleeding complications in patients with oral vitamin K antagonist therapy. Langenbecks Arch Surg (2013) 0.75